Skip to main content
Innoviva, Inc. logo

Innoviva, Inc. — Investor Relations & Filings

Ticker · INVA ISIN · US45781M1018 LEI · 549300ACOX4QTBES6535 US Financial and insurance activities
Filings indexed 1,226 across all filing types
Latest filing 2017-12-11 Regulatory Filings
Country US United States of America
Listing US INVA

About Innoviva, Inc.

https://www.inva.com/

Innoviva, Inc. is a diversified holding company that manages a portfolio of royalty-generating assets and operates a commercial-stage biopharmaceutical platform. The company's core royalty business is centered on respiratory therapies, providing a stable cash flow. Through its subsidiary, Innoviva Specialty Therapeutics, it focuses on developing and commercializing innovative treatments for patients in critical care and with infectious diseases. Innoviva's strategy involves leveraging its financial assets to invest in healthcare opportunities with high unmet medical needs, aiming to advance differentiated therapies and build a diverse portfolio of healthcare assets.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated December 8, 2017, by Innoviva, Inc. It reports a legal matter involving a court decision related to the company's board of directors, specifically about the appointment of two new board members following a proxy contest and litigation. The content focuses on a legal proceeding and its outcome rather than financial results, management changes announcement, or other report types. The document is a current report disclosing a material event, specifically a legal proceeding update and board-related outcome. This fits best under Regulatory Filings (RNS) as it is a general regulatory announcement and does not fit the more specific categories like Board/Management Information (MANG) because it is primarily about a legal ruling and its implications rather than a direct management change announcement. The document length is under 5,000 characters and contains detailed narrative about the legal case and court decision, not a report or presentation. Therefore, the classification is Regulatory Filings (RNS).
2017-12-11 English
FORM 4 -
Director's Dealing
2017-12-05 English
FORM 4 -
Director's Dealing
2017-11-22 English
FORM 4 -
Director's Dealing
2017-11-22 English
FORM 4 -
Director's Dealing
2017-11-22 English
FORM 4 -
Director's Dealing
2017-11-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.